David Altshuler is EVP, Chief Scientific Officer of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 25,813 shares of VRTX, which is worth approximately $11.9 Million. The most recent transaction as insider was on Nov 15, 2022, when has been sold 34 shares (Common Stock) at a price of $308.61 per share, resulting in proceeds of $10,492. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.8K
0% 3M change
19.43% 12M change
Total Value Held $11.9 Million

DAVID ALTSHULER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 15 2022
SELL
Open market or private sale
$10,492 $308.61 p/Share
34 Reduced 0.09%
36,077 Common Stock
Nov 07 2022
SELL
Open market or private sale
$395,069 $303.2 p/Share
1,303 Reduced 3.49%
36,077 Common Stock
Nov 07 2022
BUY
Exercise of conversion of derivative security
$244,351 $187.53 p/Share
1,303 Added 3.37%
37,380 Common Stock
Aug 08 2022
SELL
Open market or private sale
$381,811 $292.8 p/Share
1,304 Reduced 3.49%
36,077 Common Stock
Aug 08 2022
BUY
Exercise of conversion of derivative security
$244,539 $187.53 p/Share
1,304 Added 3.37%
37,381 Common Stock
Jul 19 2022
SELL
Open market or private sale
$5,148,336 $288.18 p/Share
17,865 Reduced 33.12%
36,077 Common Stock
Jul 19 2022
BUY
Exercise of conversion of derivative security
$3,047,586 $171.55 p/Share
17,765 Added 24.77%
53,942 Common Stock
Feb 25 2022
SELL
Open market or private sale
$1,749,813 $231.09 p/Share
7,572 Reduced 17.35%
36,077 Common Stock
Feb 24 2022
SELL
Payment of exercise price or tax liability
$1,375,819 $227.86 p/Share
6,038 Reduced 12.15%
43,649 Common Stock
Feb 18 2022
SELL
Open market or private sale
$996,417 $231.08 p/Share
4,312 Reduced 7.99%
49,687 Common Stock
Feb 17 2022
SELL
Payment of exercise price or tax liability
$799,602 $232.51 p/Share
3,439 Reduced 5.99%
53,999 Common Stock
Feb 14 2022
SELL
Open market or private sale
$567,057 $232.02 p/Share
2,444 Reduced 4.08%
57,438 Common Stock
Feb 11 2022
SELL
Open market or private sale
$541,150 $235.59 p/Share
2,297 Reduced 3.69%
59,882 Common Stock
Feb 10 2022
SELL
Payment of exercise price or tax liability
$836,369 $237.74 p/Share
3,518 Reduced 5.35%
62,179 Common Stock
Feb 02 2022
SELL
Open market or private sale
$1,170,033 $251.08 p/Share
4,660 Reduced 6.62%
65,697 Common Stock
Feb 02 2022
BUY
Exercise of conversion of derivative security
$403,183 $86.52 p/Share
4,660 Added 6.21%
70,357 Common Stock
Feb 01 2022
BUY
Grant, award, or other acquisition
-
32,108 Added 32.83%
65,697 Common Stock
Nov 15 2021
SELL
Open market or private sale
$6,363 $187.15 p/Share
34 Reduced 0.1%
33,589 Common Stock
May 17 2021
SELL
Open market or private sale
$17,084 $216.25 p/Share
79 Reduced 0.23%
33,589 Common Stock
Feb 25 2021
SELL
Open market or private sale
$647,356 $213.79 p/Share
3,028 Reduced 8.27%
33,589 Common Stock
Feb 24 2021
SELL
Payment of exercise price or tax liability
$525,649 $217.57 p/Share
2,416 Reduced 6.19%
36,617 Common Stock
Feb 18 2021
SELL
Open market or private sale
$1,658,509 $211.95 p/Share
7,825 Reduced 16.7%
39,033 Common Stock
Feb 17 2021
SELL
Payment of exercise price or tax liability
$1,321,320 $211.75 p/Share
6,240 Reduced 11.75%
46,858 Common Stock
Feb 11 2021
SELL
Open market or private sale
$1,114,924 $211.04 p/Share
5,283 Reduced 9.05%
53,098 Common Stock
Feb 10 2021
SELL
Payment of exercise price or tax liability
$636,912 $214.16 p/Share
2,974 Reduced 4.85%
58,381 Common Stock
DA

David Altshuler

EVP, Chief Scientific Officer
Boston, MA

Track Institutional and Insider Activities on VRTX

Follow VERTEX PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX